Envoy Medical, Inc. (COCH)

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Hearing	241.00K	225.00K	316.00K	237.00K	310.00K
Hearing Growth	7.11%	-28.80%	33.33%	-23.55%	-
Total	241.00K	225.00K	316.00K	237.00K	310.00K
Total Growth	7.11%	-28.80%	33.33%	-23.55%	-

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
United States	241.00K	225.00K	316.00K	237.00K	310.00K
United States Growth	7.11%	-28.80%	33.33%	-23.55%	-
Total	241.00K	225.00K	316.00K	237.00K	310.00K
Total Growth	7.11%	-28.80%	33.33%	-23.55%	-

Data Source: S&P Global Market Intelligence Last updated: Mar 23, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 2, 2026

Data Sources Report a data error